How Maternal Blood Pressure Influences Pregnancy and Baby Health: Insights from a Large Genetic Study

High blood pressure during pregnancy is a critical health concern for both mothers and their babies. Research consistently links elevated maternal blood pressure to adverse pregnancy and perinatal outcomes, but determining whether these relationships are causal has been challenging. A recent large-scale study published in BMC Medicine offers new insights into the effects of maternal blood pressure on pregnancy outcomes by using a genetic research method known as Mendelian randomization.

Understanding Maternal Blood Pressure and Pregnancy Risks

Approximately one in ten pregnant women experience high blood pressure, making it one of the most common medical conditions during pregnancy. Hypertensive disorders of pregnancy (HDP), which include chronic hypertension, gestational hypertension, and preeclampsia, are associated with complications such as preterm birth, fetal growth restriction, gestational diabetes, and neonatal intensive care unit (NICU) admission. These risks are more pronounced in low- and middle-income countries but are rising globally due to increasing rates of obesity and delayed maternal age at conception.

Observational studies have shown that elevated maternal blood pressure may lead to outcomes including stillbirth, gestational diabetes, labor complications, and babies born small-for-gestational age. However, observational research may be influenced by confounding factors such as maternal body mass index (BMI), socioeconomic status, and other health conditions, making it difficult to determine if high blood pressure itself directly causes these outcomes. Randomized controlled trials have also struggled to provide conclusive evidence on the effects of blood pressure treatment during pregnancy, particularly for mild to moderate hypertension.

Using Genetics to Understand Causal Relationships

To address these challenges, researchers employed a method called Mendelian randomization (MR). MR uses genetic variations as instruments to test whether a risk factor, such as blood pressure, has a causal effect on health outcomes. Since genetic variants are randomly inherited at conception, they are generally not influenced by lifestyle factors or reverse causation, providing a more reliable approach to identify causal effects compared to traditional observational studies.

This study specifically investigated the causal impact of genetically predicted maternal systolic blood pressure (SBP) and diastolic blood pressure (DBP) on a wide range of pregnancy and perinatal outcomes. The researchers analyzed data from large-scale genome-wide association studies (GWAS) involving more than 1 million participants of predominantly European ancestry. Pregnancy and perinatal outcome data included over 700,000 women, allowing for robust analyses of outcomes such as gestational diabetes, preterm birth, birth weight variations, labor induction, cesarean section, and NICU admission.

Key Findings from the Study

The study revealed that higher genetically predicted maternal blood pressure has significant effects on both maternal and fetal outcomes:

1. Gestational Diabetes: A 10 mmHg increase in maternal SBP was associated with an 11% higher risk of developing gestational diabetes. Elevated DBP showed similar trends.
2. Labor Complications: Higher blood pressure increased the likelihood of labor induction and cesarean delivery. This is consistent with clinical practice, as hypertensive disorders often prompt early intervention to reduce risks to the baby.
3. Fetal Growth and Birth Weight: Babies born to mothers with higher blood pressure were more likely to have low birth weight and be small-for-gestational age. Conversely, the odds of high birth weight or large-for-gestational age babies were reduced.
4. Preterm Birth and NICU Admission: Elevated maternal blood pressure shortened gestational duration, increasing the risk of preterm birth, including spontaneous preterm birth. It also raised the likelihood of neonatal intensive care admission.
5. No Evidence for Miscarriage or Stillbirth: Interestingly, the study found no causal relationship between genetically predicted maternal blood pressure and miscarriage or stillbirth, challenging findings from some observational studies.

These results were consistent across a range of sensitivity analyses that accounted for potential biases, such as the influence of fetal genetics, population stratification, and horizontal pleiotropy (where genetic variants affect multiple traits).

How Blood Pressure Changes During Pregnancy

During pregnancy, blood pressure naturally fluctuates. Typically, it declines in the first half of pregnancy due to lower vascular resistance and hormonal changes, such as increased relaxin production. Blood pressure then gradually rises toward term. Normal blood pressure ranges vary based on maternal characteristics such as parity, pre-pregnancy BMI, and smoking status. Chronic hypertension is defined by elevated blood pressure before 20 weeks of gestation, while gestational hypertension develops afterward.

The study confirmed that the selected genetic variants for SBP and DBP were associated with similar patterns across trimesters, supporting the validity of their MR approach. This allowed the researchers to estimate the lifetime effects of maternal blood pressure on pregnancy outcomes.

Mechanisms Linking High Blood Pressure to Adverse Outcomes

High blood pressure can impair blood flow to the placenta, reducing oxygen and nutrient delivery to the fetus. This can lead to fetal growth restriction and shorter gestation. Elevated maternal blood pressure also increases the risk of gestational diabetes, potentially due to microvascular damage that impairs insulin sensitivity. Additionally, maternal hypertension often prompts early labor induction or medically indicated preterm birth, explaining some of the observed associations with preterm birth and NICU admission.

SBP and DBP may influence pregnancy outcomes differently. Higher SBP is more likely to cause microvascular damage and cardiac remodeling, whereas elevated DBP reflects vascular resistance and arterial stiffness. This may explain why the study found more precise estimates for SBP than DBP in relation to adverse outcomes.

Implications for Clinical Practice

The findings of this study highlight the importance of monitoring and managing blood pressure in pregnant women. Lowering maternal blood pressure could have wide-ranging benefits, including reducing the risk of fetal growth restriction, preterm birth, gestational diabetes, and the need for NICU care. However, caution is warranted when translating genetic findings into clinical interventions. MR estimates reflect lifetime blood pressure variations rather than short-term changes achievable through treatment. Therefore, clinical trials are needed to determine optimal timing and dosage of antihypertensive therapies during pregnancy.

While the study suggests that controlling blood pressure is unlikely to affect miscarriage or stillbirth, monitoring maternal blood pressure remains crucial for preventing other adverse outcomes. These findings also underscore the potential for population-level interventions to improve maternal and offspring health by reducing hypertension rates.

Strengths of the Study

Several aspects strengthen the validity of the study:

• Large Sample Size: By using data from over a million participants for blood pressure and hundreds of thousands for pregnancy outcomes, the study had sufficient power to detect modest effects.
• Comprehensive Outcomes: The research examined a broad range of maternal and perinatal outcomes, providing a more complete understanding of the effects of maternal blood pressure.
• Advanced Genetic Methods: The use of Mendelian randomization and multiple sensitivity analyses reduces bias from confounding and reverse causation.
• Accounting for Fetal Genetics: Adjusting for offspring genotype ensured that observed associations reflect maternal effects rather than inherited fetal traits.

Limitations and Considerations

Despite its strengths, the study has limitations:

1. Assumptions of Mendelian Randomization: MR relies on assumptions such as instrument relevance, independence, and absence of horizontal pleiotropy. While sensitivity analyses suggest minimal bias, these assumptions cannot be fully tested.
2. Generalizability: The study population was predominantly of European ancestry and included mainly low-risk pregnancies. Findings may not fully apply to other ethnic groups or high-risk populations.
3. Interpretation of Effect Size: Genetic instruments estimate lifetime blood pressure differences. Translating these estimates to clinical interventions requires caution.
4. Nonlinear Effects: The study assumed linear effects of blood pressure on outcomes. Extreme blood pressure levels or threshold effects may not be fully captured.

Conclusion

This large genetic study provides compelling evidence that higher maternal blood pressure during pregnancy has broad negative effects on maternal and offspring health. Elevated blood pressure increases the risk of gestational diabetes, labor interventions, low birth weight, small-for-gestational age babies, preterm birth, and NICU admission. Conversely, higher maternal blood pressure does not appear to increase the risk of miscarriage or stillbirth.

These findings highlight the importance of regular blood pressure monitoring and suggest potential benefits from population-level strategies to reduce hypertension in women of reproductive age. While genetic studies cannot prescribe treatment doses or timing, the results provide strong evidence for the causal role of maternal blood pressure in pregnancy outcomes and the need for continued research on effective interventions.

Source

Fernanda Morales-Berstein, Ana Gonçalves-Soares, Qian Yang, Nancy McBride, Tom Bond, Marwa Al Arab, Alba Fernández-Sanlés, Maria C. Magnus, Eleanor Sanderson, Emma Hart, Abigail Fraser, Katherine A. Birchenall, Deborah A. Lawlor, Gemma L. Clayton, Maria-Carolina Borges. Assessing the impact of maternal blood pressure during pregnancy on perinatal health: a wide-angled Mendelian randomization study. BMC Medicine, Volume 24, Article 2 (2026).

Disclaimer

This blog is intended for educational and informational purposes only. It does not constitute medical advice and should not replace consultation with qualified healthcare professionals. Individuals with concerns about blood pressure or pregnancy outcomes should seek guidance from their obstetrician or primary care provider.